Inhibition of Parathyroid Hormone: A Dose Equivalency Study of Paricalcitol and Doxercalciferol

Publisher： Karger

E-ISSN： 1421-9670|25|6|591-595

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.25, Iss.6, 2005-11, pp. : 591-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct Effect of the Correction of Acidosis on Plasma Parathyroid Hormone Concentrations, Calcium and Phosphate in Hemodialysis Patients: A Prospective Study

By  

Nephron, Vol. 87, Iss. 3, 2001-03 ,pp. : 257-262

Karger

Access to resources Recommend Favorite

Parathyroid Hormone-Related Protein as a Renal Regulating Factor

By  

American Journal of Nephrology, Vol. 21, Iss. 3, 2001-06 ,pp. : 179-184

Karger

Access to resources Recommend Favorite

Paricalcitol and Cardiorenal Outcome: From the IMPACT Study to Clinical Practice

By  

Blood Purification, Vol. 36, Iss. 1, 2013-05 ,pp. : 12-16

Karger

Access to resources Recommend Favorite

Parathyroid Hormone Has a Prosclerotic Effect on Vascular Smooth Muscle Cells

By  

Kidney and Blood Pressure Research, Vol. 26, Iss. 1, 2003-04 ,pp. : 27-33

Karger

Access to resources Recommend Favorite

Advanced Oxidation Protein Products, Parathyroid Hormone and Vascular Calcification in Uremia

By  

Blood Purification, Vol. 20, Iss. 5, 2002-08 ,pp. : 494-497

Karger

Access to resources Recommend Favorite